<DOC>
	<DOCNO>NCT01965626</DOCNO>
	<brief_summary>Oseltamivirphosphate hydrolyse active metabolite-the free carboxylate oseltamivir . Oseltamivir neuraminidase inhibitor , serve competitive inhibitor activity viral neuraminidase ( NA ) enzyme upon sialic acid , find glycoprotein surface platelet . By block activity enzyme , oseltamivir may prevent platelet destruction liver.The project undertake Qilu Hospital Shandong University 5 well-known hospital China . In order report efficacy safety oseltamivirphosphate combine high-dose dexamethasone treatment immune thrombocytopenia ( ITP ) high platelet desialylation level , compare high-dose dexamethasone therapy .</brief_summary>
	<brief_title>A Multicenter Randomized Open-label Study Oseltamivir Combined With High-dose Dexamethasone Versus High-dose Dexamethasone Management Immune Thrombocytopenia With High Platelet Desialylation Level</brief_title>
	<detailed_description>The investigator undertake parallel group , multicentre , randomise control trial 240 newly diagnose ITP adult patient high platelet desialylation level 6 medical center China . One part participant randomly select receive oseltamivirphosphate ( oral administration dose 150 mg twice 7 consecutive day ) , combine dexamethasone ( give intravenously dose 40 mg per day 4 day , others select receive high-dose dexamethasone treatment ( give intravenously dose 40 mg daily 4 day ) . Platelet count , bleed symptom evaluate treatment . Adverse event also record throughout study . In order report efficacy safety oseltamivirphosphate combine high-dose dexamethasone therapy compare high-dose dexamethasone treatment adult newly diagnose ITP high platelet desialylation level .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>newly diagnose ITP patient high platelet desialylation level need treatment ( ) minimize risk clinically significant bleed primary ITP confirm exclude supervene cause thrombocytopenia pregnancy hypertension cardiovascular disease diabetes liver kidney function impairment HCV , HIV , HBsAg seropositive status patient systemic lupus erythematosus and/or antiphospholipid syndrome</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Oseltamivir</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>ITP</keyword>
</DOC>